Monoclonal Mouse anti‑Human KDEL Tetrapeptide Antibody (clone 1F2, Atto 488, WB) LS‑C776784
Monoclonal Mouse anti‑Human KDEL Tetrapeptide Antibody (clone 1F2, Atto 488, WB) LS‑C776784
Antibody:
KDEL Tetrapeptide Mouse anti-Human Monoclonal (Atto 488) (1F2) Antibody
Reactivity:
Human, Mouse, Rat
Format:
Atto 488, Unmodified
Overview
Antibody:
KDEL Tetrapeptide Mouse anti-Human Monoclonal (Atto 488) (1F2) Antibody
Reactivity:
Human, Mouse, Rat
Format:
Atto 488, Unmodified
Specifications
Description
KDEL Tetrapeptide antibody LS-C776784 is an Atto 488-conjugated mouse monoclonal antibody to KDEL Tetrapeptide from human. It is reactive with human, mouse and rat. Validated for WB.
Target
Human KDEL Tetrapeptide
Reactivity
Human, Mouse, Rat
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Atto 488.
Also available conjugated with
APC,
Atto 390,
Atto 594,
Biotin,
FITC,
PerCP,
RPE.
Purification
Protein G purified
Immunogen
KDEL peptide (C-AVKDEL -COOH) conjugated at the N-Terminus to Bovine Serum Albumin (BSA)
Specificity
Detects KDEL tagged proteins.
Applications
- Western blot (1:1000)
- Applications tested for the base form of this product only
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.4, 0.09% Sodium Azide, 50% Glycerol
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat, Hamster
Applications:
IHC, IHC - Paraffin, ICC, Western blot
Species:
Rat
Applications:
ICC, Western blot, ELISA
Reactivity:
Rat
Range:
1.56-100 ng/ml
Species:
Human
Applications:
IHC, IHC - Paraffin, ICC, Immunofluorescence, Peptide Enzyme-Linked Immunosorbent Assay
Species:
M13 Bacteriophage
Applications:
IHC, ELISA
Reactivity:
Human
Range:
123.5-10000 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/26/2024